David Diemert, MD
Enriched profileProfessor of Medicine; Professor of Microbiology, Immunology, and Tropical Medicine; Professor of Epidemiology; Director, GW Vaccine Research Unit · George Washington University School of Medicine and Health Sciences
David Diemert is Professor of Medicine; Professor of Microbiology, Immunology, and Tropical Medicine; Professor of Epidemiology; Director, GW Vaccine Research Unit at George Washington University School of Medicine and Health Sciences. OpenAlex indexes 147 publications with 17,366 citations (h-index 40); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 24 Oct 2026
David Diemert, MD, is Professor of Medicine at George Washington University School of Medicine and Health Sciences. The public record shows 147 publications with 17,366 citations (h-index 40), centered on Parasites and Host Interactions, Parasitic Diseases Research and Treatment, Helminth infection and control. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 2 companies, 4 NIH-funded awards (2015–2025).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: Parasites and Host Interactions
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 75.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Sponsor: International AIDS Vaccine Initiative
- Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
Sponsor: George Washington University
- A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults
Sponsor: International AIDS Vaccine Initiative
Industry payments
Updated 24 Oct 2026
2 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- PFIZER INC.Program year20252 payments
- Merck Sharp & Dohme LLCProgram year20243 payments
NIH funding
Updated 24 Oct 2026
4 NIH research awards on record, funded 2015–2025 per NIH RePORTER. The latest:
- Planning for Na-GST-1 Hookworm Vaccine Phase 2 CHIM Efficacy Trial
George Washington University
FY2025$242,058R34AI189333 - Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists
George Washington University
FY2022$480,908U01AI129789 - Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists
George Washington University
FY2020$731,524U01AI129789
Publications
Updated 24 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Influenza A and B Viral Shedding in Adults Immunized With Live Attenuated Influenza Vaccine.
Clinical infectious diseases
Article2026 - Precise targeting of HIV broadly neutralizing antibody precursors in humans.
Science (New York, N.Y.)
Clinical Trial2025 - Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
Science (New York, N.Y.)
Clinical Trial2025 - Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Nature communications
Clinical Trial2025 - Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.
PLoS neglected tropical diseases
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)- 01Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineArticle10,092 citations2020
- 02Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookwormArticle2,482 citations2006
- 03Hookworm infectionReview338 citations2016
- 04Vaccination induces HIV broadly neutralizing antibody precursors in humansArticle278 citations2022
- 05Developing vaccines to combat hookworm infection and intestinal schistosomiasisReview252 citations2010
Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-diemert-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
faculty.smhs.gwu.edu/david-joseph-diemert
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.smhs.gwu.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.smhs.gwu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.smhs.gwu.edu ↗
- Fellow of the Royal College of Physicians (Canada); Board Certified in Internal Medicine
Infectious Diseases, and Medical Microbiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.smhs.gwu.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →faculty.smhs.gwu.edu ↗
Editorial & leadership roles
journal and society appointments- Co-Director
Immunohematology and Infection Block, preclinical medical student curriculum at George Washington University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.smhs.gwu.edu ↗
Secondary affiliations
appointments beyond the home institution- International AIDS Vaccine Initiative (IAVI)
funded researcher
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.smhs.gwu.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →smhs.gwu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →smhs.gwu.edu ↗
- The Kojo Nnamdi Show
discussion of COVID-19 vaccine trial progress and expectations
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →smhs.gwu.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital